230 related articles for article (PubMed ID: 645575)
1. Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA
Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575
[No Abstract] [Full Text] [Related]
2. Electrophysiologic effects of encainide (MJ 9067) on canine Purkinje fibres.
Gibson JK; Somani P; Bassett AL
Eur J Pharmacol; 1978 Nov; 52(2):161-9. PubMed ID: 729630
[No Abstract] [Full Text] [Related]
3. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
Koerpel BJ; Davis LD
Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676
[No Abstract] [Full Text] [Related]
4. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
Damiano BP; Stump GL; Yagel SK
J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
[TBL] [Abstract][Full Text] [Related]
5. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
Kinnaird AA; Man RY
Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of the new antiarrhythmic drug 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide++ + on dog cardiac muscle.
Sato Y; Iijima T; Taira N
Arzneimittelforschung; 1989 Jan; 39(1):56-9. PubMed ID: 2719743
[TBL] [Abstract][Full Text] [Related]
7. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
[TBL] [Abstract][Full Text] [Related]
8. The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
Spear JF; Moore EN
Pacing Clin Electrophysiol; 1982 Mar; 5(2):238-50. PubMed ID: 6176964
[No Abstract] [Full Text] [Related]
9. Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
Somani P; Kumakura S
Recent Adv Stud Cardiac Struct Metab; 1973; 3():367-85. PubMed ID: 4806661
[No Abstract] [Full Text] [Related]
10. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
Arnsdorf MF; Mehlman DJ
J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
[No Abstract] [Full Text] [Related]
11. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
Arnsdorf MF
J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217
[No Abstract] [Full Text] [Related]
12. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
Camm AJ
Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
[No Abstract] [Full Text] [Related]
13. Cardiac electrophysiologic effects of R 54718.
Johnson N; Spinelli W; Rosen MR
Eur J Pharmacol; 1987 Mar; 135(1):41-51. PubMed ID: 3569425
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
Kinnaird AA; Man RY
Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
Carmeliet E
Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
Carmeliet E
Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
[No Abstract] [Full Text] [Related]
17. Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine.
Rosen MR; Hoffman BF; Wit AL
Am Heart J; 1975 Apr; 89(4):526-36. PubMed ID: 1090140
[No Abstract] [Full Text] [Related]
18. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
Hoffman BF
J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
[TBL] [Abstract][Full Text] [Related]
19. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
Arnsdorf MF; Sawicki GJ
J Pharmacol Exp Ther; 1989 Mar; 248(3):1158-66. PubMed ID: 2495352
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
Wit AL; Hoffman BF; Rosen MR
Am Heart J; 1975 Dec; 90(6):795-803. PubMed ID: 903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
